SHLMedicalannouncesstrategicallianceprogramforautoinjectorservices|SHLMedical

InOneSEOPack 3.6.2ob_start_detected [-1,-1] 

In One SEO Pack 

 End Google Tag Manager 

 Google Tag Manager (noscript) 

 End Google Tag Manager (noscript) 

SHL at a glance 

- Patient Health and Independence 

- 

SHL at a glance
Who we are and what we do

Medtech & Industrial CDMO 

Ecological Footprint
Patient Health and Independence

SHL at a glance
Who we are and what we do

Medtech & Industrial CDMO 

Responsible Business Practices
Ecological Footprint
Patient Health and Independence

 <a href="javascript:;" class="_menu"><svg class="icon icon-search"><use xlink:href="#icon-search"></use></svg></a> 

Search

 <a class="language_zh" target="_blank" href="http://zh.shl.group/">中文</a> 

All

All

 Breadcrumb NavXT 6.3.0 
Home / News /  /  announces strategic alliance program for autoinjector services 

 announces strategic alliance program for autoinjector services
SHL Medical partners with key players within the drug delivery ecosystem to offer optimized services and recommendation for combination product development.

SHL Medical, a world-leading solutions provider of advanced drug delivery systems such as autoinjectors and innovative specialty delivery systems, has announced the creation of a global Alliance Management program with a selection of solutions providers along the drug delivery value chain.

Driven by its purpose to enable patients’ independence, SHL Medical has been an instrumental partner to several of the world’s leading pharma and biotech companies in pioneering patient-centric, self-injection solutions that support the enhancement of patients’ quality of life. Leveraging its comprehensive in-house development and manufacturing capabilities, SHL Medical provides its customers with end-to-end solutions and services, from design and development to final assembly, labeling, and packaging, as well as connected technologies for digital healthcare.

The Alliance Management program will further strengthen SHL Medical’s vertically integrated business model by facilitating customer engagement with other key players within the drug delivery ecosystem, including primary container providers, CMOs/CDMOs, and various service providers and suppliers of the primary and secondary packaging of the drug product. In its inception, the program will primarily be focused on enhancing SHL Medical’s Molly® modular autoinjector platform offering to ensure that customers have seamless access to a full network of solutions and services that support faster development and simplified supply chain management. The program will allow each of the partners to offer their expert advice, recommendations, and competencies that best cater to the customer’s needs for combination product development.

“Autoinjector development encompasses an intricate network of competencies that each contribute to the successful delivery of a combination product,” said Markus Puusepp, Chief Growth Officer at SHL Medical. “By enhancing the technical integration across various stages of the combination product value chain, these newly formed alliances will continue to generate added value for our customers while fostering a more collaborative culture where partners can leverage and build upon each other’s expertise and knowledge to enhance the drug delivery industry for the betterment of patient care.”

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem. ​

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

SHL Latest News
ten23 health® and SHL Medical announce a strategic partnership agreement for integrated servicesSHL Medical returns to CPHI Japan 2024SHL Medical joins DCAT Week 2024SHL Medical partners with SteriPack Group to set up final assembly serviceSHL Medical exhibits at SCbio 2024SHL Medical further strengthens vertical capabilities with the acquisition of US manufacturer Superior Tooling Inc.FUJIFILM Diosynth Biotechnologies and SHL Medical enter strategic partnership agreement to help meet growing market demand for autoinjector medicinesSHL Medical kicks off 2024 with participation in Pharmapack EuropeSHL wins big in continuous improvementAchieving low-carbon-emission medical devicesSHL Medical achieves EcoVadis® Silver Medal and sets ambitious science-based climate targetsSHL Medical’s climate targets officially approved by Science Based Targets initiative (SBTi) 

SHL Medical

ten23 health® and SHL Medical announce a strategic partnership agreement for integrated services 

ten23 health®, a leading Swiss Contract Development and Manufacturing Organization (CDMO) for sterile drugs, and SHL Medical, a world-leading provider of drug delivery devices, today announced their strategic partnership.

SHL Medical

SHL Medical partners with SteriPack Group to set up final assembly service 

SHL Medical, a world-leading solutions provider of advanced drug delivery systems and SteriPack Group, renowned global supplier of secondary packing and final assembly services to the pharmaceutical industry, enter a non-exclusive strategic partnership.

SHL Medical

SHL Medical further strengthens vertical capabilities with the acquisition of US manufacturer Superior Tooling Inc. 

Continuing its ambitious growth journey, SHL Medical has acquired Superior Tooling Inc., a US-based manufacturing company specializing in plastic injection molds.

search

Your browser is out-of-date!

Update your browser to view this website correctly. Update